Position in AVLN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$329,200
New position
Shares Held
10,000
first reported quarter
Ownership
0.023%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#71
of 92 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026SOROS FUND MANAGEMENT LLC holds $118,020,895 across 9 Biotechnology names. AVLN ranks #7 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APGE |
Apogee Therapeutics, Inc.
|
564,500 | $74,926,085 | |
| 2 | TECH |
BIO-TECHNE Corp
|
535,400 | $37,826,010 | |
| 3 | AKTS |
Aktis Oncology, Inc.
|
100,000 | $3,223,000 | |
| 4 | COAG |
Hemab Therapeutics Holdings, Inc.
|
25,000 | $918,250 | |
| 5 | KLRA |
Kailera Therapeutics, Inc.
|
20,000 | $440,600 | |
| 6 | KARD |
Kardigan, Inc.
|
15,000 | $357,750 | |
| 7 | AVLN |
Avalyn Pharma Inc.
This page
|
10,000 | $329,200 | |
| 8 | CPRX |
Catalyst Pharmaceuticals, Inc.
|
344,593 | $0 |
All Filings in AVLN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $329,200 | 10,000 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||